On how data-based evidence is beneficial for the cannabis industry for changing minds
The language of data gets everybody excited. I love when a client comes back and asks 10,000 questions that we don’t know the answer to because, to get to those questions, we must answer 1,000,000 questions that nobody else could answer.
What the international cannabis landscape will look like in 5 years
I think, in five years, shipping cannabis across the world will probably be a little bit hard. I think every country will want to have its own product, and they will probably try to make it more difficult to get products cheaper from outside. And I say that because I am thinking about Mexico and Brazil.
Now, you’re hearing about a lot of U.K. companies who are cultivating the U.K. and Brexit, so I think about things like lead times, for instance. Those are the type of things that we think about. How do we improve lead times? How do we get the product faster from one place to the next?
Alvaro Torres – Co-Founder, CEO and Director at Khiron Life Sciences Corp
Reducing opioid dependency and improving medical patient access to cannabis covered by insurance
I think Columbia’s one of the most advanced countries when it comes to the regulation of medical cannabis. It is true that it’s only focused on oils and extracts as a medical market, but it’s also true that the government has unequivocally decided to cover medical cannabis for patients. You think of other countries that have this, [and] you think about Germany but not the United States.
Editors’ Note: This is an excerpt from our Monthly Playbook. If you would like to read the full monthly playbook and join the thousands of others you can sign up below.
